首页 > 市场调查报告书 > 製药

妇科治疗

市场调查报告书

商品编码

1604173

全球不孕症药物市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势与预测

Global Infertility Drugs Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年11月01日 | 出版商:

Value Market Research | 英文 170 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

全球不孕症药物市场需求预计将从 2023 年的 42.3 亿美元达到近 75.9 亿美元的市场规模，2024-2032 年研究期间复合年增长率为 6.72%。

不孕症药物是一种旨在解决荷尔蒙失衡和阻碍受孕的生殖问题的药物治疗方法。这些药物旨在刺激排卵、改善精子生成或调节荷尔蒙週期，从而增加成功怀孕的机会。常见的药物包括排卵刺激剂，如克罗米芬柠檬酸盐和促性腺激素，有助于诱导女性排卵，以及用于男性的睪固酮或荷尔蒙疗法等药物，以增强精子的产生。此外，一些药物针对特定的生殖疾病或影响生育能力的潜在疾病。透过纠正荷尔蒙缺乏或改善生殖功能，这些药物在辅助生殖治疗中发挥着至关重要的作用。

市场动态

受生活方式因素、高龄和生殖疾病发病率上升的影响，不孕症盛行率不断上升，是主要的市场驱动因素。随着越来越多的个人和夫妇寻求治疗方案，对有效不孕症药物的需求不断增长。生殖医学的技术进步和创新为市场扩张提供了巨大的机会。新型和改进的生育药物的开发，包括新型荷尔蒙疗法和标靶治疗，正在提高不孕症治疗的有效性和安全性。这些进步使得更个人化的治疗计划和更高的生育治疗成功率成为可能。辅助生殖技术（ART）的日益普及也推动了对不孕症药物的需求。随着体外受精 (IVF) 等 ART 手术变得越来越普遍，对优化治疗结果和提高生育成功率的支持性药物的需求也在不断增长。此外，生育诊所和专门生殖健康中心的扩大为增加药物使用提供了机会。这些设施提供全面的治疗选择和个人化护理，推动了对各种不孕症药物的需求。关于不孕不育和现有治疗方法的公众意识活动和教育倡议有助于市场成长。随着意识的提高，越来越多的人寻求医疗帮助并探索基于药物的解决方案来应对生育挑战。然而，与不孕症药物和治疗相关的高成本以及有限的保险范围可能会抑制市场成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具也对全球不孕症药物市场的各个细分市场进行了包容性评估。不孕症药物产业的成长和趋势为这项研究提供了整体方法。

市场区隔

不孕症药物市场报告的这一部分提供了国家和区域层面细分市场的详细资料，从而帮助策略师确定相应产品或服务的目标人群以及即将到来的机会。

按药物类别

促性腺激素
芳香酶抑制剂
选择性雌激素受体调节剂 (SERM)
多巴胺激动剂
其他的

按配销通路

医院药房
专业及零售药房
网路药房

按最终用户

男士
女性

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲不孕症药物市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。不孕症药物市场的主要参与者包括默沙东公司、Ferring BV、Organon Group Of Companies、雅培、诺华公司、拜耳公司、辉瑞公司、Mankind Pharma、梯瓦製药工业有限公司、赛诺菲。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

区域展望
介绍
北美销售分析
- 概览、历史与预测资料销售分析
- 北美按细分市场销售分析
- 北美按国家销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
欧洲销售分析
- 概览、历史与预测资料销售分析
- 欧洲按细分市场销售分析
- 欧洲按国家销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 义大利销售分析
- 俄罗斯销售分析
- 欧洲其他地区销售分析
亚太地区销售分析
- 概览、历史与预测资料销售分析
- 亚太地区按细分市场销售分析
- 亚太地区按国家销售分析
- 中国销售分析
- 印度销售分析
- 日本销售分析
- 韩国销售分析
- 澳洲销售分析
- 东南亚销售分析
- 亚太地区其他地区销售分析
拉丁美洲销售分析
- 概览、历史与预测资料销售分析
- 拉丁美洲按细分市场销售分析
- 拉丁美洲按国家销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利销售分析
- 拉丁美洲其他地区销售分析
中东和非洲销售分析
- 概览、历史与预测资料销售分析
- 中东和非洲按细分市场销售分析
- 中东和非洲按国家销售分析
- 沙乌地阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 中东其他地区和非洲销售分析

第 9 章：不孕症药品公司的竞争格局

不孕不育药物市场竞争
伙伴关係/协作/协议
併购
新产品发布
其他发展

第 10 章：公司简介

顶级公司市占率分析
市场集中度
Merck & Co. Inc.

公司概况
公司收入
产品
最新动态

Ferring BV

公司概况
公司收入
产品
最新动态

Organon Group Of Companies

公司概况
公司收入
产品
最新动态

Abbott

公司概况
公司收入
产品
最新动态

Novartis AG

公司概况
公司收入
产品
最新动态

Bayer AG

公司概况
公司收入
产品
最新动态

Pfizer Inc.

公司概况
公司收入
产品
最新动态

Mankind Pharma

公司概况
公司收入
产品
最新动态

Teva Pharmaceutical Industries Ltd.

公司概况
公司收入
产品
最新动态

Sanofi

公司概况
公司收入
产品
最新动态

註 - 在公司概况中，财务详细资讯和最新发展视情况而定，或对私人公司而言可能不包括在内

简介目录图表

Product Code: VMR112115478

The global demand for Infertility Drugs Market is presumed to reach the market size of nearly USD 7.59 Billion by 2032 from USD 4.23 Billion in 2023 with a CAGR of 6.72% under the study period 2024-2032.

Infertility drugs are pharmaceutical treatments designed to address hormonal imbalances and reproductive issues that hinder conception. These medications aim to stimulate ovulation, improve sperm production, or regulate hormonal cycles, thereby increasing the chances of successful pregnancy. Common drugs include ovulation stimulants like clomiphene citrate and gonadotropins, which help induce ovulation in women, and medications like testosterone or hormone therapies for men to enhance sperm production. Additionally, some drugs target specific reproductive disorders or underlying conditions affecting fertility. By correcting hormonal deficiencies or improving reproductive function, these drugs play a crucial role in assisted reproductive treatments.

MARKET DYNAMICS

The rising prevalence of infertility, influenced by lifestyle factors, advanced age, and increasing rates of reproductive disorders, is a primary market driver. As more individuals and couples seek treatment options, the demand for effective infertility drugs is growing. Technological advancements and innovations in reproductive medicine present substantial opportunities for market expansion. The development of new and improved fertility drugs, including novel hormone therapies and targeted treatments, is enhancing the efficacy and safety of infertility management. These advancements enable more personalized treatment plans and higher success rates for fertility treatments. The increasing adoption of assisted reproductive technologies (ART) is also driving demand for infertility drugs. As ART procedures such as in vitro fertilization (IVF) become more prevalent, the need for supportive medications that optimize treatment outcomes and enhance fertility success is growing. Moreover, the expansion of fertility clinics and specialized reproductive health centers provides opportunities for increased drug utilization. These facilities offer comprehensive treatment options and personalized care, driving demand for a wide range of infertility medications. Public awareness campaigns and educational initiatives about infertility and available treatments contribute to market growth. As awareness increases, more individuals are seeking medical help and exploring drug-based solutions to address fertility challenges. However, high costs associated with infertility drugs and treatments, along with limited insurance coverage, may restrain market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Infertility Drugs. The growth and trends of Infertility Drugs industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Infertility Drugs market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Drug Class

Gonadotropins
Aromatase Inhibitors
Selective Estrogen Receptor Modulators (SERMs)
Dopamine Agonists
Others

By Distribution Channel

Hospital Pharmacy
Specialty & Retail Pharmacy
Online Pharmacy

By End-user

Men
Women

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Infertility Drugs market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Infertility Drugs market include Merck & Co. Inc., Ferring B.V., Organon Group Of Companies, Abbott, Novartis AG, Bayer AG, Pfizer Inc., Mankind Pharma, Teva Pharmaceutical Industries Ltd., Sanofi. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. INFERTILITY DRUGS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Drug Class
- 3.7.2 Market Attractiveness Analysis By Distribution Channel
- 3.7.3 Market Attractiveness Analysis By End-user
- 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL INFERTILITY DRUGS MARKET ANALYSIS BY DRUG CLASS

5.1. Overview By Drug Class
5.2. Historical and Forecast Data Analysis By Drug Class
5.3. Gonadotropins Historic and Forecast Sales By Regions
5.4. Aromatase Inhibitors Historic and Forecast Sales By Regions
5.5. Selective Estrogen Receptor Modulators (SERMs) Historic and Forecast Sales By Regions
5.6. Dopamine Agonists Historic and Forecast Sales By Regions
5.7. Others Historic and Forecast Sales By Regions

6. GLOBAL INFERTILITY DRUGS MARKET ANALYSIS BY DISTRIBUTION CHANNEL

6.1. Overview By Distribution Channel
6.2. Historical and Forecast Data Analysis By Distribution Channel
6.3. Hospital Pharmacy Historic and Forecast Sales By Regions
6.4. Specialty & Retail Pharmacy Historic and Forecast Sales By Regions
6.5. Online Pharmacy Historic and Forecast Sales By Regions

7. GLOBAL INFERTILITY DRUGS MARKET ANALYSIS BY END-USER

7.1. Overview By End-user
7.2. Historical and Forecast Data Analysis By End-user
7.3. Men Historic and Forecast Sales By Regions
7.4. Women Historic and Forecast Sales By Regions

8. GLOBAL INFERTILITY DRUGS MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE INFERTILITY DRUGS COMPANIES

9.1. Infertility Drugs Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF INFERTILITY DRUGS INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Merck & Co. Inc.
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. Ferring B.V.
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. Organon Group Of Companies
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. Abbott
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. Novartis AG
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. Bayer AG
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
10.9. Pfizer Inc.
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments
10.10. Mankind Pharma
- 10.10.1 Company Overview
- 10.10.2 Company Revenue
- 10.10.3 Products
- 10.10.4 Recent Developments
10.11. Teva Pharmaceutical Industries Ltd.
- 10.11.1 Company Overview
- 10.11.2 Company Revenue
- 10.11.3 Products
- 10.11.4 Recent Developments
10.12. Sanofi
- 10.12.1 Company Overview
- 10.12.2 Company Revenue
- 10.12.3 Products
- 10.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

简介目录图表

LIST OF TABLES

Market Snapshot
Drivers: Impact Analysis
Restraints: Impact Analysis
List of Raw Material
List of Raw Material Manufactures
Analysis By Drug Class (USD MN)
Gonadotropins Market Sales By Geography (USD MN)
Aromatase Inhibitors Market Sales By Geography (USD MN)
Selective Estrogen Receptor Modulators (SERMs) Market Sales By Geography (USD MN)
Dopamine Agonists Market Sales By Geography (USD MN)
Others Market Sales By Geography (USD MN)
Analysis By Distribution Channel (USD MN)
Hospital Pharmacy Market Sales By Geography (USD MN)
Specialty & Retail Pharmacy Market Sales By Geography (USD MN)
Online Pharmacy Market Sales By Geography (USD MN)
Analysis By End-user (USD MN)
Men Market Sales By Geography (USD MN)
Women Market Sales By Geography (USD MN)
Global Infertility Drugs Market Sales By Geography (USD MN)
North America Market Analysis (USD MN)
United States Market Analysis (USD MN)
Canada Market Analysis (USD MN)
Mexico Market Analysis (USD MN)
Europe Market Analysis (USD MN)
Europe Market Estimate By Country (USD MN)
United Kingdom Market Analysis (USD MN)
France Market Analysis (USD MN)
Germany Market Analysis (USD MN)
Italy Market Analysis (USD MN)
Russia Market Analysis (USD MN)
Spain Market Analysis (USD MN)
Rest of Europe Market Analysis (USD MN)
Asia Pacific Market Analysis (USD MN)
China Market Analysis (USD MN)
Japan Market Analysis (USD MN)
India Market Analysis (USD MN)
South Korea Market Analysis (USD MN)
Australia Market Analysis (USD MN)
South East Asia Market Analysis (USD MN)
Rest of Asia Pacific Market Analysis (USD MN)
Latin America Market Analysis (USD MN)
Brazil Market Analysis (USD MN)
Argentina Market Analysis (USD MN)
Peru Market Analysis (USD MN)
Chile Market Analysis (USD MN)
Rest of Latin America Market Analysis (USD MN)
Middle East & Africa Market Analysis (USD MN)
Saudi Arabia Market Analysis (USD MN)
UAE Market Analysis (USD MN)
Israel Market Analysis (USD MN)
South Africa Market Analysis (USD MN)
Rest of Middle East and Africa Market Analysis (USD MN)
Partnership/Collaboration/Agreement
Mergers And Acquisition

LIST OF FIGURES

Research Scope of Infertility Drugs Report
Market Research Process
Market Research Methodology
Global Infertility Drugs Market Size, By Region (USD MN)
Porters Five Forces Analysis
Market Attractiveness Analysis By Drug Class
Market Attractiveness Analysis By Distribution Channel
Market Attractiveness Analysis By End-user
Market Attractiveness Analysis By Region
Value Chain Analysis
Global Market Analysis By Drug Class (USD MN)
Gonadotropins Market Sales By Geography (USD MN)
Aromatase Inhibitors Market Sales By Geography (USD MN)
Selective Estrogen Receptor Modulators (SERMs) Market Sales By Geography (USD MN)
Dopamine Agonists Market Sales By Geography (USD MN)
Others Market Sales By Geography (USD MN)
Global Market Analysis By Distribution Channel (USD MN)
Hospital Pharmacy Market Sales By Geography (USD MN)
Specialty & Retail Pharmacy Market Sales By Geography (USD MN)
Online Pharmacy Market Sales By Geography (USD MN)
Global Market Analysis By End-user (USD MN)
Men Market Sales By Geography (USD MN)
Women Market Sales By Geography (USD MN)
Global Market Sales (USD MN)
North America Market Sales (USD MN)
Europe Market Sales (USD MN)
Asia Pacific Market Sales (USD MN)
Latin America Market Sales (USD MN)
Middle East & Africa Market Sales (USD MN)
Recent Development in Industry
Top Company Market Share Analysis